L-Asparaginsaeure en es it fr

L-Asparaginsaeure Brand names, L-Asparaginsaeure Analogs

L-Asparaginsaeure Brand Names Mixture

  • No information avaliable

L-Asparaginsaeure Chemical_Formula


L-Asparaginsaeure RX_link

No information avaliable

L-Asparaginsaeure fda sheet

L-Asparaginsaeure msds (material safety sheet)


L-Asparaginsaeure Synthesis Reference

No information avaliable

L-Asparaginsaeure Molecular Weight

133.104 g/mol

L-Asparaginsaeure Melting Point

230 oC

L-Asparaginsaeure H2O Solubility

4.5 g/l

L-Asparaginsaeure State


L-Asparaginsaeure LogP

-0.67 +/- 0.36

L-Asparaginsaeure Dosage Forms

Capsules and powder

L-Asparaginsaeure Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

L-Asparaginsaeure Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

L-Asparaginsaeure Absorption

Absorbed from the small intestine by an active transport process

L-Asparaginsaeure side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

L-Asparaginsaeure Patient Information

No information avaliable

L-Asparaginsaeure Organisms Affected

Humans and other mammals